These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 8618285)

  • 41. [T1G3 bladder tumors: our experience].
    Pagano S; Franzoso F; Pachera F; Ruggeri P; Sorboli G
    Arch Ital Urol Androl; 1996 Feb; 68(1):39-45. PubMed ID: 8664920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Locally advanced and metastatic bladder cancer.
    Dreicer R
    Curr Treat Options Oncol; 2001 Oct; 2(5):431-6. PubMed ID: 12057106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Editorial Comment to Cancer death from non-muscle invasive bladder cancer: Report of the Japanese Urological Association of data from the 1999-2001 registry in Japan.
    Koga F
    Int J Urol; 2010 Nov; 17(11):913. PubMed ID: 20969638
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder.
    Vallo S; Gilfrich C; Burger M; Volkmer B; Boehm K; Rink M; Chun FK; Roghmann F; Novotny V; Mani J; Brisuda A; Mayr R; Stredele R; Noldus J; Schnabel M; May M; Fritsche HM; Pycha A; Martini T; Wirth M; Roigas J; Bastian PJ; Nuhn P; Dahlem R; Haferkamp A; Fisch M; Aziz A
    Urol Oncol; 2016 Oct; 34(10):432.e1-8. PubMed ID: 27283218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Usefulness of radiotherapy in the treatment of infiltrating bladder cancer].
    Escudero Barrilero A
    Arch Esp Urol; 1990; 43 Suppl 2():165-84. PubMed ID: 1710884
    [No Abstract]   [Full Text] [Related]  

  • 46. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
    Tran E; Souhami L; Tanguay S; Rajan R
    Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.
    Freiha F; Reese J; Torti FM
    J Urol; 1996 Feb; 155(2):495-9; discussion 499-500. PubMed ID: 8558644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Infiltrating transitional carcinoma of the bladder (4). Our approach to stage pT2 and critique of other risk factors. Multifactorial analysis].
    Escudero Barrilero A; Perales L; Romero J; Rodríguez Luna JM; Vallejo J; Rivas JA
    Actas Urol Esp; 1991; 15(5):411-20. PubMed ID: 1807119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [T1G3 bladder neoplasms: treatment and results].
    Cosciani Cunico S; Magri V; Aulenti V; Tosana M; Botturi A
    Arch Ital Urol Androl; 1996 Feb; 68(1):47-50. PubMed ID: 8664921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Why has the prognosis for muscle-invasive bladder cancer not significantly improved after decades of therapeutic advancements?
    Goto T; Miyamoto H
    Expert Rev Anticancer Ther; 2020 Apr; 20(4):229-231. PubMed ID: 32208041
    [No Abstract]   [Full Text] [Related]  

  • 51. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.
    Alfred Witjes J; Lebret T; Compérat EM; Cowan NC; De Santis M; Bruins HM; Hernández V; Espinós EL; Dunn J; Rouanne M; Neuzillet Y; Veskimäe E; van der Heijden AG; Gakis G; Ribal MJ
    Eur Urol; 2017 Mar; 71(3):462-475. PubMed ID: 27375033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.
    Koukourakis MI; Tsolos C; Touloupidis S
    Urology; 2007 Feb; 69(2):245-50. PubMed ID: 17320657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [pT1G3 bladder carcinoma: our experience].
    Dell'Orto P; Trinchieri A; D'Addezio F; Bernardini P; Mangiarotti B; Del Nero A; Pisani E
    Arch Ital Urol Androl; 1996 Feb; 68(1):9-11. PubMed ID: 8664927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can bladder preservation therapy come to the center stage?
    Inamoto T; Ibuki N; Komura K; Juri H; Yamamoto K; Yamamoto K; Fujita K; Nonomura N; Narumi Y; Azuma H
    Int J Urol; 2018 Feb; 25(2):134-140. PubMed ID: 29171098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database.
    Fischer-Valuck BW; Rao YJ; Rudra S; Przybysz D; Germino E; Samson P; Baumann BC; Gay H; Michalski J
    J Urol; 2018 Feb; 199(2):416-423. PubMed ID: 28842247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of systemic chemotherapy and intra-arterial chemotherapy with/without radiotherapy for bladder preservation or as neo-adjuvant therapy in patients with muscle-invasive bladder cancer: a single-centre study of 163 patients.
    Miyata Y; Nomata K; Ohba K; Matsuo T; Hayashi N; Sakamoto I; Uetani M; Sakai H
    Eur J Surg Oncol; 2015 Mar; 41(3):361-7. PubMed ID: 25312685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Southwest Oncology Group Study 8710: trial of cystectomy alone versus neo-adjuvant M-VAC and cystectomy in patients with locally advanced bladder cancer (Intergroup Trial 0080).
    Crawford ED; Natale RB; Burton H
    Prog Clin Biol Res; 1990; 353():111-3. PubMed ID: 2217407
    [No Abstract]   [Full Text] [Related]  

  • 58. Expression of S100A2 and S100A4 predicts for disease progression and patient survival in bladder cancer.
    Matsumoto K; Irie A; Satoh T; Ishii J; Iwabuchi K; Iwamura M; Egawa S; Baba S
    Urology; 2007 Sep; 70(3):602-7. PubMed ID: 17688917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Organ preservation in superficial bladder cancer.
    Oosterhof GO; Witjes JA; Debruyne FM
    Prog Clin Biol Res; 1991; 370():195-202. PubMed ID: 1924451
    [No Abstract]   [Full Text] [Related]  

  • 60. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
    Maarouf AM; Khalil S; Salem EA; ElAdl M; Nawar N; Zaiton F
    BJU Int; 2011 May; 107(10):1605-10. PubMed ID: 20825396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.